Cargando…
HIF-1 and tumour radiosensitivity
Hypoxia-inducible factor-1 (HIF-1) plays important roles in regulating radiosensitivity, making it a potentially promising target for tumour radiosensitisation. Here, we discuss the rationale for, and the potential pitfalls of, combining HIF-1 blockade with radiotherapy. In doing so, we describe cli...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360497/ https://www.ncbi.nlm.nih.gov/pubmed/16735998 http://dx.doi.org/10.1038/sj.bjc.6603201 |
_version_ | 1782153063791853568 |
---|---|
author | Moeller, B J Dewhirst, M W |
author_facet | Moeller, B J Dewhirst, M W |
author_sort | Moeller, B J |
collection | PubMed |
description | Hypoxia-inducible factor-1 (HIF-1) plays important roles in regulating radiosensitivity, making it a potentially promising target for tumour radiosensitisation. Here, we discuss the rationale for, and the potential pitfalls of, combining HIF-1 blockade with radiotherapy. In doing so, we describe clinical scenarios in which HIF-1 inhibition might optimise tumour radiosensitivity. |
format | Text |
id | pubmed-2360497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23604972009-09-10 HIF-1 and tumour radiosensitivity Moeller, B J Dewhirst, M W Br J Cancer Minireview Hypoxia-inducible factor-1 (HIF-1) plays important roles in regulating radiosensitivity, making it a potentially promising target for tumour radiosensitisation. Here, we discuss the rationale for, and the potential pitfalls of, combining HIF-1 blockade with radiotherapy. In doing so, we describe clinical scenarios in which HIF-1 inhibition might optimise tumour radiosensitivity. Nature Publishing Group 2006-07-03 2006-05-30 /pmc/articles/PMC2360497/ /pubmed/16735998 http://dx.doi.org/10.1038/sj.bjc.6603201 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Minireview Moeller, B J Dewhirst, M W HIF-1 and tumour radiosensitivity |
title | HIF-1 and tumour radiosensitivity |
title_full | HIF-1 and tumour radiosensitivity |
title_fullStr | HIF-1 and tumour radiosensitivity |
title_full_unstemmed | HIF-1 and tumour radiosensitivity |
title_short | HIF-1 and tumour radiosensitivity |
title_sort | hif-1 and tumour radiosensitivity |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360497/ https://www.ncbi.nlm.nih.gov/pubmed/16735998 http://dx.doi.org/10.1038/sj.bjc.6603201 |
work_keys_str_mv | AT moellerbj hif1andtumourradiosensitivity AT dewhirstmw hif1andtumourradiosensitivity |